| scholarly article | Q13442814 |
| P50 | author | Rayaz Malik | Q30429930 |
| Andrew Boulton | Q43143923 | ||
| Akbar Vohra | Q72281674 | ||
| P2093 | author name string | D Liu | |
| C Li | |||
| S Kumar | |||
| D McLeod | |||
| J V Forrester | |||
| J A Olson | |||
| K C McHardy | |||
| P B Wilson | |||
| W Aziz | |||
| P2860 | cites work | Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer | Q28141264 |
| Defective angiogenesis in mice lacking endoglin | Q28144833 | ||
| CD105 is important for angiogenesis: evidence and potential applications | Q28207439 | ||
| Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury | Q28215010 | ||
| Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development | Q28585397 | ||
| A murine model of hereditary hemorrhagic telangiectasia | Q28592376 | ||
| Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy | Q34402812 | ||
| Plaque angiogenesis: its functions and regulation | Q35176925 | ||
| Diabetic nephropathy and retinopathy | Q35861770 | ||
| Transcriptional regulation of the Vascular Endothelial Growth Factor gene--a concert of activating factors | Q36017173 | ||
| CD105 prevents apoptosis in hypoxic endothelial cells | Q42441203 | ||
| TNF alpha down-regulates CD105 expression in vascular endothelial cells: a comparative study with TGF beta 1. | Q44486980 | ||
| Serum levels of vascular endothelial growth factor (VEGF) are markedly elevated in patients with Wegener's granulomatosis. | Q50533750 | ||
| Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays. | Q51618784 | ||
| CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells | Q58297995 | ||
| Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy | Q70664870 | ||
| Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin | Q73738309 | ||
| The significance of CD105, TGFbeta and CD105/TGFbeta complexes in coronary artery disease | Q74341199 | ||
| Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis | Q74462138 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 692-697 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy | |
| P478 | volume | 9 |
| Q36906436 | Developmental regulation of NO-mediated VEGF-induced effects in the lung |
| Q53637738 | Diabetic macular ischaemia is associated with narrower retinal arterioles in patients with type 2 diabetes. |
| Q28071774 | Endothelial Microparticles Act as Novel Diagnostic and Therapeutic Biomarkers of Diabetes and Its Complications: A Literature Review |
| Q35459633 | Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6) |
| Q34621295 | Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy |
| Q33492339 | Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy |
| Q37678807 | Mediators of ocular angiogenesis |
| Q37697860 | Plasma and vitreous fluid levels of Dickkopf-1 in patients with diabetic retinopathy |
| Q35739660 | Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy |
| Q58703191 | Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia |
| Q37071368 | Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy |
| Q37545245 | The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects |
| Q50947386 | The effect of a systemic angiotensin receptor blocker on vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy. |
| Q36425846 | The effect of intravitreal vascular endothelial growth factor on inner retinal oxygen delivery and metabolism in rats |
| Q27028225 | Vitreous mediators in retinal hypoxic diseases |
Search more.